According to the best cutoff value of MYH9 expression, we assigned HCC patients into two groups and found that MYH9 expression levels were positively associated with poor patient prognosis based on TCGA database analysis (Supplementary Fig. 6e). This evidence concerns the gene MYH9 and hepatocellular carcinoma.